SGLT-2 inhibitors significantly reduce death and hospitalisations for heart failure: Astrazeneca…
The study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced all-cause mortality…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.